e-learning
resources
Amsterdam 2015
Tuesday, 29.09.2015
Immune mechanisms in the human lung
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Should patients with mild asthma be excluded from allergic rhinitis drug trials?
Anne Marie Salapatek (Mississauga, Canada), Anne Marie Salapatek, Peter Couroux, Victoria Nelson, Piyush Patel
Source:
International Congress 2015 – Immune mechanisms in the human lung
Session:
Immune mechanisms in the human lung
Session type:
Thematic Poster Session
Number:
4026
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Anne Marie Salapatek (Mississauga, Canada), Anne Marie Salapatek, Peter Couroux, Victoria Nelson, Piyush Patel. Should patients with mild asthma be excluded from allergic rhinitis drug trials?. Eur Respir J 2015; 46: Suppl. 59, 4026
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Asthma control with omalizumab treatment in severe allergic asthma and severe non-allergic asthma patients
Source: International Congress 2015 – Asthma and lung immunology
Year: 2015
Comparative efficacy of different groups of drugs for the treatment of bronchial asthma in combination with allergic rhinitis
Source: International Congress 2014 – Intervening in allergic asthma
Year: 2014
Combined therapy of asthma and allergic rhinitis
Source: Annual Congress 2013 –Treatment of asthma
Year: 2013
Treatment and outcomes in patients with asthma and allergic rhinitis
Source: Eur Respir J 2005; 26: Suppl. 49, 576s
Year: 2005
APEXII- A prospective study investigating the efficacy of omalizumab treatment in severe allergic asthma
Source: International Congress 2015 – Immune aspects of asthma and other airway diseases
Year: 2015
First clinical trial of a new IgE-adsorber in allergic asthma
Source: International Congress 2015 – Novel mechanisms and treatments in allergy and asthma
Year: 2015
QAV680, cetirizine and their combination reduce nasal symptoms in patients with intermittent allergic rhinitis in an environmental exposure chamber
Source: International Congress 2014 – Allergy and asthma: novel findings based on human cell biology
Year: 2014
Risk factors of incomplete asthma control in asthmatic patients with allergic rhinitis
Source: Annual Congress 2013 –Asthma
Year: 2013
Inflammatory profile of patients with allergic asthma & rhinitis
versus
patients with allergic rhinitis alone
Source: Annual Congress 2007 - Mechanisms of inflammation in asthma and rhinitis - from cell cultures to patients
Year: 2007
Allergic rhinitis and coexistence of allergic rhinitis and asthma at Greek children. Comparison of clinical and laboratory pararameters
Source: Eur Respir J 2006; 28: Suppl. 50, 255s
Year: 2006
Evaluation of asthma patients using the control of allergic rhinitis and asthma test (CARAT)
Source: Annual Congress 2012 - Phenotypes and mechanisms of treatment of asthma
Year: 2012
Asthma among allergic rhinitis patients
Source: Eur Respir J 2003; 22: Suppl. 45, 108s
Year: 2003
Allergy markers in relation to allergic rhinitis and asthma in relatives of asthmatics in the EGEA study
Source: Eur Respir J 2003; 22: Suppl. 45, 115s
Year: 2003
The ’real-life’ long-term efficacy of omalizumab in severe persistent IgE-mediated allergic asthma in Malta
Source: International Congress 2016 – Asthma management
Year: 2016
Long-term using of omalizumab in children with atopic severe persistent non-controlled asthma
Source: Annual Congress 2013 –Uncontrolled and severe asthma in children
Year: 2013
Allergic rhinitis and asthma: combined syndrome, unified treatment
Source: Eur Respir J 2003; 22: Suppl. 45, 134s
Year: 2003
Persistent allergic sensitization is associated with asthma and rhinitis among adults
Source: International Congress 2016 – Asthma and allergy in infancy: from risk factors to mortality
Year: 2016
Anti-IgE: lessons from clinical trials in patients with severe allergic asthma symptomatic despite optimised therapy
Source: Eur Respir Rev 2007; 16: 73-77
Year: 2007
The evaluations of allergic rhinitis symptoms in patients with asthma and allergic rhinitis with the addiing of montelukast in asthma treatment
Source: Eur Respir J 2004; 24: Suppl. 48, 124s
Year: 2004
Immunotherapy prevents the development of asthma in subjects with allergic rhinitis
Source: Eur Respir J 2001; 18: Suppl. 33, 482s
Year: 2001
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept